Market Tracker

10/30 11:09am ET

Trovagene Inc (NASDAQ:TROV)

4.60
Data as of 10:52am ET
 +0.21 / +4.78%
Today’s Change
2.97
Today|||52-Week Range
7.10
-19.86%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.39
Today’s open4.40
Day’s range4.40 - 4.60
Volume20,175
Average volume (3 months)167,856
Market cap$83.0M
Dividend yield--
Data as of 10:52am ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book4.07

Competitors

 Today’s
change
Today’s
% change
LPDXLipoScience Inc+0.01+0.19%
CGIXCancer Genetics Inc-0.09-1.19%
PANGPanacea Global Inc-0.17-32.06%
GALTGalectin Therapeutic...-0.00-0.04%
Data as of 11:05am ET, 10/30/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts